Stakeholders build capacity for local production of WHO pre-qualified medicines Post published:September 22, 2023 Post category:Uncategorized Concerned that none of the over 120 pharmaceutical manufacturers in the country is pre-qualified by the World Health Organisation (WHO) to produce medicines for global procurement and use, stakeholders have renewed their efforts to address the gaps. Please Share This Share this content Opens in a new window Opens in a new window Opens in a new window Opens in a new window Opens in a new window Opens in a new window Opens in a new window Opens in a new window Opens in a new window Opens in a new window You Might Also Like The VC of University of Port harcourt visits NNMDA, signs an MoU for research partnership September 12, 2022 NNMDA Empowers Youths with Cassava Cultivation Training for Pharmaceutical Products December 9, 2024 NAPA Visits NNMDA DG to Strengthen Research Collaboration February 10, 2026
The VC of University of Port harcourt visits NNMDA, signs an MoU for research partnership September 12, 2022
